Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / Common Stock, $0.0001 Par Value
-
Shares outstanding
-
9.65M
-
Number of holders
-
91
-
Total 13F shares, excl. options
-
24.9M
-
Shares change
-
+176K
-
Total reported value, excl. options
-
$234M
-
Value change
-
+$136K
-
Put/Call ratio
-
1.72
-
Number of buys
-
46
-
Number of sells
-
-37
-
Price
-
$9.38
Significant Holders of Athira Pharma, Inc. - Common Stock, $0.0001 Par Value (ATHA) as of Q3 2021
110 filings reported holding ATHA - Athira Pharma, Inc. - Common Stock, $0.0001 Par Value as of Q3 2021.
Athira Pharma, Inc. - Common Stock, $0.0001 Par Value (ATHA) has 91 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 24.9M shares
.
Largest 10 shareholders include PERCEPTIVE ADVISORS LLC (3.43M shares), FRANKLIN RESOURCES INC (2.08M shares), BlackRock Inc. (2.01M shares), RTW INVESTMENTS, LP (1.91M shares), Logos Global Management LP (1.86M shares), VANGUARD GROUP INC (1.64M shares), VR Adviser, LLC (1.2M shares), PATHSTONE FAMILY OFFICE, LLC (1.15M shares), CITADEL ADVISORS LLC (1.14M shares), and WASATCH ADVISORS INC (896K shares).
This table shows the top 91 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.